Human Papillomavirus Vaccination and Screening in the Elimination of HPV-Associated Cancers: Evidence-Based Randomized Trials (Original Publisher)
$28.00
Accelerate your understanding of HPV prevention and cancer control with Human Papillomavirus Vaccination and Screening in the Elimination of HPV-Associated Cancers. This 2024 publication from Bentham Science delivers evidence-based analysis from randomized clinical trials, offering essential guidance for clinicians, researchers, and public health professionals working to eliminate HPV-related cancers through vaccination and screening programs.
Description
Human Papillomavirus Vaccination and Screening in the Elimination of HPV-Associated Cancers: Evidence-Based Randomized Trials is a pivotal reference for anyone involved in cancer prevention, women’s health, public health policy, or infectious disease research. With HPV being a leading cause of cervical and other anogenital and oropharyngeal cancers, this book presents a comprehensive, evidence-based exploration of clinical strategies for eliminating these cancers through widespread vaccination and organized screening efforts.
The book is tailored for gynecologists, oncologists, public health policymakers, epidemiologists, infectious disease researchers, and students in medical and health sciences. It emphasizes the latest randomized clinical trial outcomes and their real-world implications, making it a valuable tool for bridging science with effective health policy.
Key Features and Highlights:
- Published in 2024 by Bentham Science, delivering the latest research-based insights.
- Focuses on HPV vaccination programs, screening methodologies, and elimination strategies.
- Summarizes high-impact randomized clinical trials with practical implementation data.
- Addresses both high-income and low-resource country contexts for global applicability.
- Explores screening technologies, vaccine efficacy, immunization policies, and health system challenges.
- Supports health professionals in developing or improving national HPV control programs.
Chapters & Topics Covered:
Although specific chapter titles are not available, this eBook includes core chapters on:
- HPV epidemiology and cancer burden
- Clinical trial evidence for vaccine efficacy and safety
- Screening technologies and guidelines (Pap, HPV DNA testing, co-testing)
- Vaccine implementation in adolescent and adult populations
- Integration of screening and vaccination strategies in public health programs
- Global perspectives on HPV-related cancer elimination strategies
- Challenges in low- and middle-income countries
About the Author:
Authored and edited by leading medical researchers and public health experts specializing in HPV, cervical cancer prevention, and vaccine program implementation. Their combined expertise spans global clinical trials, policy development, and academic research.
Format & Technical Details:
- Available Formats: PDF
- File Size: Approximately 12–14 MB
- Language: English
- Device Compatibility: Fully compatible with Kindle, iOS, Android, PC, and Mac using standard PDF
Frequently Asked Questions
Q1: Is this book relevant for clinicians involved in HPV vaccination programs?
Yes. This book is highly relevant for clinicians, gynecologists, and public health practitioners involved in designing, delivering, or evaluating HPV vaccination and screening initiatives.
Q2: Does the book include global data and case studies from low-resource settings?
Absolutely. The book provides a global perspective, including randomized trial evidence and implementation challenges in both high-income and resource-limited countries.
Additional information
Publisher |
Bentham Science |
---|---|
Published Year |
2024 |
Language |
English |
ISBN |
978-9815305500 |
File Size |
89.1 MB |
Edition |
1 |
Reviews
There are no reviews yet.